3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
86
Phase 1
82
Phase 1/2
26
Phase 2
22
Phase EARLY_PHASE1
10
Phase 3
9
Phase 4
2
Phase 2/3
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
37
Genitourinary
2
Breast
2
Thoracic
1
Sarcoma
1
Other
1
Head & Neck
1
Gynecologic
1
Dermatologic
1
Conditions
Breast Neoplasms
276
Pain, Postoperative
14
Neoplasm Metastasis
12
Neoplasms
9
Prostatic Neoplasms
8
Ovarian Neoplasms
7
Triple Negative Breast Neoplasms
6
Pain
6
Osteoporosis
6
Seroma
5
Colorectal Neoplasms
5
Cardiotoxicity
5
Breast Diseases
4
Breast Cancer Female
4
Neutropenia
3
Melanoma
3
Mastodynia
3
Lymphedema
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Brain Neoplasms
3
Bone Diseases, Metabolic
3
Vomiting
2
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Sleep Initiation and Maintenance Disorders
2
Skin Diseases
2
Obesity
2
Neurotoxicity Syndromes
2
Multiple Myeloma
2
Interventions
Sevoflurane
2
Propofol
2
Isoflurane
1
Desflurane
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Colonic Neoplasms
×
Breast
×
Clear all
NCT01975064
2022-12-14
CAN
Uppsala University
Phase 4
Completed
5,774 enrolled
NCT04074460
2022-06-09
VAPOR-C
Peter MacCallum Cancer Centre, Australia
Phase 4
Completed
169 enrolled